Search clinical trials for: NHS-IL12

Total 1249 results

RWTH Aachen University

Completed

Identification of Microcirculation and Inflammation After Minimal-invasive Osteosynthesis of the Proximal Femur (MicroProxFem)

Level of Pain

Germany
Nantes University Hospital

Completed

Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplant (HILDEGAZ)

Hematopoietic Stem Cell Transplantation

France
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Study of HS-10517 in Chinese Adult Participants

COVID-19

China
Vanderbilt University Medical Center
American Cancer Society, Inc.

Completed

New Modalities for Detection of Oropharyngeal Cancer

Oropharynx Cancer | Tonsil Cancer | Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma | Base of Tongue Carcinoma

United States
Hansoh BioMedical R&D Company

Not yet recruiting

Study of HS-20105 for Injection in Patients With Advanced Solid Tumors.

Advanced Solid Tumor
Hansoh BioMedical R&D Company

Recruiting

ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Head and Neck Squamous Cell Carcinoma

China
Hansoh BioMedical R&D Company

Recruiting

ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC)

Metastasis Castration Resistant Prostate Cancer(mCRPC)

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Hase 1/2 Study of HS-10375 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)

Advanced or Metastatic NSCLC

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Active, not recruiting

A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC

Nonsmall Cell Lung Cancer

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors

Solid Tumor

China
HeadSense Medical
University of Maryland, College Park

Unknown

An Evaluation of Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm

Subarachnoid Hemorrhage | Vasospasm, Intracranial

United States
HeadSense Medical

Suspended

An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring Device

Stroke | Brain Injuries | Brain Neoplasms | Intracranial Hypertension | Hydrocephalus

Japan
HeadSense Medical
Elisabeth-TweeSteden Ziekenhuis

Completed

Prospective Evaluation of the Non-invasive ICP HeadSense Monitor in TBI Patients Undergoing Invasive ICP Monitoring

Brain Injuries | Intracranial Hypertension

Netherlands
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients

Diabetes Mellitus, Type 2

China
Philip Morris Products S.A.

Withdrawn

Effect of Switching From Cigarette Smoking to THS on Systemic Endothelial Function in Subjects With Established Atherosclerotic Disease

Cardiovascular Diseases | Coronary Artery Disease | Smoking | Peripheral Arterial Disease | Tobacco Use
University Hospital, Strasbourg, France

Completed

Severe PID With Lymphoproliferation and Neutropenia (DICEP)

Primary Immune-Deficiency (PID) Common Variable Immune Deficiency (CVID)

France
Sahlgrenska University Hospital, Sweden

Completed

The Effect of Parkinson Kinetigraph Recordings on the Management and Outcome in Parkinson's Disease

Parkinson Disease

Sweden
Sino-Swed Pharmaceutical Corporation
Wuhan TongJi Hospital; Guangzhou S Y S Medical School hospital; Beijing 301 hospital and other collaborators

Completed

The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients

Postoperative Complications | Gastrointestinal Neoplasms

China
Philip Morris Products S.A.

Recruiting

Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms.

Smoking | Tobacco Use | COPD

United States, Bulgaria, Czechia, Germany, Japan, Romania, Slovakia, United Kingdom
Hellenic Institute for the Study of Sepsis
The BioArte

Completed

NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification (BIOARTE)

Pneumonia | Bacteremia | Acute Pyelonephritis | Biliary Tract Infection

Greece
Hangzhou Normal University

Completed

Behavioral Assessment of Nociception on NCS-R

Disorder of Consciousness | Minimally Conscious State | Unresponsive Wakefulness Syndrome

China
Ruhr University of Bochum

Completed

Pain-related Evoked Potentials in Unilateral Peripheral Nerve Injuries

Peripheral Nerve Injuries
Nicole Hamblett
University of Washington; Dartmouth-Hitchcock Medical Center; Cystic Fibrosis...

Completed

Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study (SIMPLIFY-HS)

Cystic Fibrosis

United States
Heat Biologics

Completed

A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors

Advanced Solid Tumor

United States
Beijing 302 Hospital

Not yet recruiting

Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years

HBeAg Positive Chronic Hepatitis B

China
Third Affiliated Hospital, Sun Yat-Sen University
Peking University; First People's Hospital of Foshan; Shenzhen Third People's...

Unknown

The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg

Chronic Hepatitis B

China
Sarepta Therapeutics, Inc.
United States Department of Defense

Withdrawn

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Ebola Hemorrhagic Fever

United States
University Health Network, Toronto

Completed

Can Ultrasound Detect Diabetic Peripheral Neuropathy?

Distal Symmetric Polyneuropathy (DSPN)

Canada
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Renal Cell Carcinoma
Hansoh BioMedical R&D Company

Recruiting

ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas

Sarcoma | Osteosarcoma

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer

Advanced Non-Small-Cell Lung Cancer

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors

Solid Tumor

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

A Study of HS-10342 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

China
Atridia Pty Ltd.

Completed

A Phase I Trial of HS-10241 in Solid Tumors

Solid Tumors | Neoplasm

Australia
NS Pharma, Inc.

Completed

Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

Primary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis

United States
Universitätsmedizin Mannheim

Withdrawn

HS-PCI in Locally Advanced Adenocarcinoma of the Lung (HIPPO-S)

Adenocarcinoma | Lung Cancer | Lymphatic Metastasis
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours

Carcinoma | Solid Tumor, Adult

China
HeadSense Medical
Oslo University Hospital

Completed

Development and Evaluation of the ICP Waveform Tracing Capabilities and Safety of HS-1000 Device

Brain Injuries | Intracranial Hypertension

Norway
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.

CML, Chronic Phase | CML, Accelerated Phase

China
Butler Hospital
University of North Carolina, Chapel Hill; Neurolief Ltd.

Enrolling by invitation

EEG Biomarker Study for Participants in the Neurolief "MOOD" Trial

Depression

United States
Novartis

Completed

The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.

Bipolar Disorder
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostatic Cancer

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Phase 1/2 Study of HS-10370 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Herbert Lyerly

Terminated

A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies

Solid Tumor

United States
HeadSense Medical
Rigshospitalet, Denmark

Unknown

Comparison of the Non-invasive ICP HeadSense Monitor vs Lumbar CSF Pressure Measurement

Intracranial Hypertension

Denmark, Germany, Netherlands
HeadSense Medical
State Medical Center, Republic of Armenia

Completed

An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Routine Care

Stroke

Armenia
Boehringer Ingelheim

Completed

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Parkinson Disease

United States, Canada
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder

Insomnia Disorder

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC

Non Small Cell Lung Cancer

China

Search clinical trials for: NHS-IL12

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations